Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effekten av fysisk trening på muskelskvalitet, kroppssammensetning og funksjonell respons hos individer etter fedmekirurgi (BAR-EX)

22. september 2026 oppdatert av: María José Pabst, Universidad Autónoma de Chile

Effect of a Concurrent Exercise Program on Muscle Quality, Body Composition, Functional Response, and Quality of Life in Individuals Undergoing Bariatric Surgery: Protocol for a Randomized Controlled Clinical Trial

This study aims to evaluate the effect of a 5-week concurrent exercise program (aerobic and resistance training) on muscle quality, body composition, functional response, and quality of life in individuals undergoing bariatric surgery.

This is a single-center, prospective, longitudinal, randomized controlled clinical trial with two parallel groups: an intervention group and a control group. A total of 87 adults aged 18 to 60 years who have undergone sleeve gastrectomy or Roux-en-Y gastric bypass and have a medical indication for metabolic rehabilitation will be recruited.

The intervention group will participate in a structured, semi-supervised concurrent exercise program for 5 weeks, consisting of two in-person sessions per week (10 sessions in total), whereas the control group will continue receiving usual kinesiology care and standard clinical management according to the institutional rehabilitation protocol at Clínica BUPA Santiago. All participants will be assessed at two time points: baseline, during the fourth postoperative week, and at week 7.

The primary outcome will be the change in rectus femoris muscle quality assessed by ultrasound (echo intensity). Secondary outcomes will include body composition (bioelectrical impedance analysis), functional response (One-minute Sit-to-Stand Test), and quality of life (Moorehead-Ardelt II questionnaire).

Additionally, adherence to the exercise program in the intervention group will be assessed as the percentage of attendance at supervised exercise sessions, and its association with the magnitude of changes in study outcomes will be explored.

The findings are expected to provide clinically relevant evidence regarding the effectiveness of exercise during the early postoperative period and to contribute to the optimization of metabolic rehabilitation strategies following bariatric surgery.

Studieoversikt

Detaljert beskrivelse

Bariatric surgery is an effective treatment for severe obesity; however, the early postoperative period is frequently associated with loss of lean body mass, reduced muscle strength, and functional decline, which may negatively affect recovery and quality of life. Physical exercise has been proposed as a key component of metabolic rehabilitation, although evidence regarding structured concurrent exercise programs initiated early after bariatric surgery remains limited, particularly with respect to muscle quality.

The aim of this study is to evaluate the effect of a 5-week concurrent exercise program on rectus femoris muscle quality in individuals undergoing bariatric surgery, compared with a control group receiving usual kinesiology care. Secondary objectives include evaluating changes in body composition, functional response, and quality of life, as well as exploring the association between exercise adherence and the magnitude of observed changes.

This is a single-center, prospective, longitudinal, randomized controlled clinical trial with two parallel groups (intervention and control). A total of 87 adults aged 18-60 years who have undergone sleeve gastrectomy or Roux-en-Y gastric bypass at Clínica BUPA Santiago and have a medical indication for metabolic rehabilitation will be recruited. Participants will undergo baseline assessment during the fourth postoperative week and will then be randomly allocated in a 1:1 ratio to the intervention or control group using a sequence generated and administered by an individual independent of the assessors and treating physical therapists.

The intervention group will participate in a structured, semi-supervised 5-week concurrent exercise program designed according to the FITT principle (Frequency, Intensity, Time, and Type of exercise). The program will combine aerobic and resistance training and will include two supervised in-person sessions per week (10 sessions in total) plus one complementary home-based session each week. Aerobic training will progress from continuous moderate-intensity exercise to interval training, whereas resistance training will progressively increase training volume for large muscle groups. Exercise intensity will be monitored using the Borg Rating of Perceived Exertion scale, and resistance loads will be individually adjusted according to each participant's clinical tolerance.

Participants allocated to the control group will continue receiving usual kinesiology care and standard clinical management according to the institutional metabolic rehabilitation protocol at Clínica BUPA Santiago. This program will also follow the FITT principle and will include two supervised sessions per week consisting of continuous aerobic exercise, targeted muscle strengthening, and static stretching, consistent with routine clinical practice, without the structured progression incorporated into the concurrent exercise program.

Following the 5-week intervention period, both groups will complete one week without supervised exercise sessions to minimize the acute effects of exercise on muscle measurements. Final assessments will be performed at week 7.

The primary outcome will be the change in rectus femoris muscle quality assessed by musculoskeletal ultrasound using echo intensity as the primary indicator. Secondary outcomes will include body composition assessed by bioelectrical impedance analysis, functional response assessed using the One-minute Sit-to-Stand Test, and quality of life assessed using the Moorehead-Ardelt II questionnaire.

Exercise adherence will be assessed exclusively in the intervention group as the percentage of attendance at supervised exercise sessions. The association between adherence and the magnitude of outcome changes will also be explored using a dose-response approach.

Statistical analyses will follow the intention-to-treat principle. The primary analysis will be performed using analysis of covariance (ANCOVA), with study group as the fixed factor and baseline values as covariates, adjusting for prespecified clinically relevant covariates when appropriate. Secondary outcomes will be analyzed using the same approach. Complementary analyses will include within- and between-group comparisons using parametric or non-parametric tests according to data distribution, estimation of effect sizes, and exploratory correlation and linear regression analyses to evaluate the association between exercise adherence and changes in study outcomes.

Studietype

Intervensjonell

Registrering (Antatt)

87

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Santiago Metropolitan
      • Santiago, Santiago Metropolitan, Chile, 7820830
        • Rekruttering
        • Clínica BUPA, Santiago
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tomás Vergara Soria, Kinesiólogo

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 60 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria

  • Adults aged 18-60 years.
  • Participants eligible for the institutional PAD (Pago Asociado a Diagnóstico) bariatric surgery program with medical indication for metabolic rehabilitation.
  • Undergoing sleeve gastrectomy or Roux-en-Y gastric bypass at Clínica BUPA Santiago.
  • Medical indication for metabolic rehabilitation.
  • Able and willing to provide written informed consent.

Exclusion Criteria

  • Type 1 diabetes mellitus or type 2 diabetes mellitus with severe complications (including stage G4-G5 nephropathy, severe autonomic neuropathy, or high risk of exercise-related hypoglycemia).
  • Severe musculoskeletal disorders limiting participation in the exercise program.
  • Acute cardiovascular event within the previous 3 months or medical contraindication to supervised exercise.
  • Severe cardiorespiratory disease or dyspnea at rest or with minimal exertion.
  • Dependence on supplemental oxygen.
  • Bariatric surgery complications (e.g., leak, bleeding, stenosis, or intra-abdominal abscess).
  • Liver failure, kidney failure, or any other clinical condition compromising safe participation in the exercise program.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Concurrent Physical Exercise Program

Participants allocated to the intervention group will complete a structured, semi-supervised concurrent exercise program during the postoperative period following bariatric surgery. Participants will enter the study during postoperative week 4 and undergo a baseline assessment before starting the intervention. The program will last 5 weeks and will include 10 supervised in-person sessions (2 sessions/week, approximately 60 minutes each) and one complementary home-based session per week. After completion of the intervention, participants will remain one week without supervised exercise sessions before the week 7 follow-up assessment.

Concurrent physical exercise program of 5 weeks combining aerobic and resistance training in individuals undergoing bariatric surgery. The program includes two supervised in-person sessions per week (10 sessions total), each lasting approximately 60 minutes, and one recommended weekly home-based session guided by a prescribed exercise plan.

Aerobic exercise is performed at moderate to high intensity, monitored using the Borg Rating of Perceived Exertion scale. Resistance training targets major muscle groups and is prescribed based on an estimated one-repetition maximum (1RM), with progression in volume and intensity according to individual tolerance and safety criteria.

The program begins at postoperative week 4. After completing the 5-week intervention, participants undergo a 1-week period without supervised sessions before the post-intervention assessment.

Andre navn:
  • Concurrent Physical Exercise Program
Aktiv komparator: Usual Metabolic Rehabilitation Program

Participants allocated to the control group will receive the usual metabolic rehabilitation program at Clínica BUPA Santiago. The rehabilitation program will follow the FITT principle (Frequency, Intensity, Time, and Type of exercise) and will include two supervised sessions per week for 5 weeks consisting of continuous aerobic exercise, targeted muscle strengthening, and stretching according to the institutional protocol. All participants will undergo baseline and week 7 assessments.

Usual institutional metabolic rehabilitation program at Clínica BUPA Santiago based on the FITT principle (Frequency, Intensity, Time, and Type of exercise). The program includes supervised continuous aerobic exercise, targeted muscle strengthening, and stretching delivered twice weekly for 5 weeks according to the institutional clinical protocol.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in rectus femoris muscle quality (echo intensity; grayscale units 0-255)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Muscle quality will be assessed by ultrasound as echo intensity (mean grayscale value, 0-255) within a standardized region of interest, analyzed using ImageJ, at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in percent body fat (%)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Percent body fat (%) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in fat mass (kg)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Fat mass (kg) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in skeletal muscle mass (kg)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Skeletal muscle mass (kg) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in 1-minute Sit-to-Stand performance (1min-STST)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Functional response will be assessed using the One-minute Sit-to-Stand Test (1min-STST). The primary metric is the total number of completed repetitions in 60 seconds performed using a standard chair. Perceived exertion (modified Borg scale) may be recorded as a complementary measure.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Adherence to the exercise program (supervised in-clinic sessions)
Tidsramme: During the 5-week intervention period (calculated at the end of the program based on attendance to the 10 supervised sessions).

Attendance rate to supervised in-clinic sessions at Clínica BUPA during the intervention. Adherence will be calculated as: adherence (%) = (number of attended sessions / 10) × 100. For descriptive purposes, adherence will be categorized as high (8-10 sessions; ≥80%), moderate (6-7 sessions; 60-79%), and low (0-5 sessions; <60%). Adherence ≥80% will be considered clinically acceptable.

During the 5-week intervention period (calculated at the end of the program based on attendance to the 10 supervised sessions).
Change in visceral fat area (cm²)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Visceral fat area (cm²) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in basal metabolic rate (kcal/day)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Body composition will be assessed using bioelectrical impedance analysis (InBody S10) under standardized conditions before and after the intervention. Basal metabolic rate (kcal/day) will be recorded at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in rectus femoris muscle thickness (cm)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

ectus femoris muscle thickness (cm) will be assessed by ultrasound under standardized conditions at baseline and post-intervention. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in rectus femoris cross-sectional area (cm²)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Rectus femoris cross-sectional area (cm²) will be assessed by ultrasound under standardized conditions at baseline and post-intervention. Change will be calculated as Δ = post - pre

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).
Change in intramuscular fat infiltration assessed by ultrasound echo intensity (grayscale units 0-255)
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of intervention and 1 week of rest).

Intramuscular fat infiltration will be assessed by musculoskeletal ultrasound using rectus femoris echo intensity (grayscale units 0-255) under standardized acquisition conditions. Images will be analyzed using ImageJ. Change will be calculated as Δ = post - pre.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of intervention and 1 week of rest).
Change in quality of life assessed by the Moorehead-Ardelt II questionnaire
Tidsramme: Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Quality of life will be assessed using the Moorehead-Ardelt II questionnaire, a bariatric surgery-specific instrument that evaluates domains including self-esteem, physical well-being, social relationships, work, and sexuality. Total score (and domain scores, if applicable) will be compared before and after the intervention.

Baseline (pre-intervention) and 7 weeks after baseline (after 5 weeks of exercise and 1 week of rest).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Samarbeidspartnere

Etterforskere

  • Hovedetterforsker: María José Pabst Pérez, MSc, Universidad Autónoma de Chile
  • Studiestol: Luis Astete, MSc, Universidad Autónoma de Chile
  • Studiestol: Nicolas Arancibia Ramirez, Kinesiólogo, Clinica Alemana
  • Studieleder: Rosario Alonso Domínguez, PhD., Universidad de Salamanca. España
  • Studieleder: María de la Luz Tocino, PhD., University of Salamanca
  • Studieleder: Matias Otto Yañez, PhD., Universidad Autónoma de Chile. Chile
  • Studiestol: Paloma Lillo, MsC, Universidad Silva Henriquez
  • Studiestol: Carla Martinez Dominguez, Kinesióloga, Clinica Bupa Santiago
  • Hovedetterforsker: Tomás Vergara Soria, Kinesiólogo, Clínica BUPA Santiago
  • Studiestol: Sebastian Barrios Valenzuela, Kinesiólogo, Clínica BUPA Santiago
  • Studiestol: Erika Troncoso, MsC, Clinica las Condes
  • Studiestol: Karen Castañeda Lavin, MsC, University of Americas - Chili

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

11. august 2025

Primær fullføring (Antatt)

31. desember 2027

Studiet fullført (Antatt)

31. desember 2028

Datoer for studieregistrering

Først innsendt

14. november 2025

Først innsendt som oppfylte QC-kriteriene

17. februar 2026

Først lagt ut (Faktiske)

20. februar 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

25. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

22. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) will not be publicly shared to protect patient confidentiality. Only aggregated and anonymized results will be disseminated through scientific publications or presentations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere